60 leading groups and individuals representing the patient and disability communities signed onto the Partnership to Improve Patient Care's (PIPC) comment letter to the Department of Health and Human Services (HHS) opposing the Trump administration's Most Favored Nations (MFN) rulemaking.
|
"We support the agency’s goal of lowering drug prices for all Americans, but it is critical that it is done in ways that work for all Americans," the letter states. "The MFN rule ignores the boundaries of statute creating the Center for Medicare and Medicaid Innovation that were put in place to protect patients, would import discriminatory standards for policymaking used in MFN nations, and lead directly to lack of access to needed treatments for many Americans. "
The letter in its entirety can be read here.

pipc_stakeholder_comment_on_importing_qalys_final.pdf |